Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Marçalo (Aveiro, Portugal), S. Neto (Aveiro, Portugal), M. Pinheiro (Aveiro, Portugal), A. Rodrigues (Braga, Portugal), N. Sousa (Braga, Portugal), M. Santos (Aveiro, Portugal), P. Simão (Porto, Portugal), C. Valente (Aveiro, Portugal), L. Andrade (Aveiro, Portugal), A. Marques (Aveiro, Portugal), G. Moura (Aveiro, Portugal). The worldwide covid-19 genetic risk scenario. 675

Member's Comments

No comment yet.

Related content which might interest you: Individual susceptibility to environmental risks Source: Annual Congress 2007 - Individual susceptibility to environmental risks Year: 2007 The influence of genetics on mortality from pneumonia Source: Annual Congress 2005 - Outcome in severe pneumonia Year: 2005 Novel strategy to identify genetic risk factors for COPD severity: a genetic isolate Source: Eur Respir J 2010; 35: 768-775 Year: 2010 Effectiveness of favipiravir in COVID-19 patients with risk factors for mortality: A real world experience from India. Source: Virtual Congress 2021 – COVID - 19 treatments Year: 2021 Novel strategy to identify genetic risk factors for COPD severity: genetically isolated populations Source: Annual Congress 2008 - Genetic risk factors for asthma and COPD Year: 2008 Smoking is a risk factor for TB infection, but is it an additional mortality risk? Source: Annual Congress 2011 - Management of tuberculosis Year: 2011 Epidemiology of COVID-19: global spread, risk factors for disease incidence, severity and mortality Source: Eur Respir Monogr 2021; 94: 14-27 Year: 2021 The results of the TB control during of it epidemic in Ukraine on the base of the TB incidence in risk groups studying Source: Eur Respir J 2003; 22: Suppl. 45, 518s Year: 2003 Identification of novel rare genetic variants associated with COPD in the general population Source: International Congress 2018 – Multiomics studies in epidemiology: what can they tell us? Year: 2018 COVID-19 prevalence, risk factors and outcomes in COPD Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021 Will the population ²at risk for COPD² develop COPD? Source: Eur Respir J 2005; 26: Suppl. 49, 218s Year: 2005 The problem of early mortality in pneumococcal pneumonia: a study of risk factors Source: Eur Respir J 2015; 46: 561-564 Year: 2015 The social and structural determinants of tuberculosis incidence trends in 116 countries from 2005-2015: an ecological study Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases Year: 2021 Impact of clinical and socio-economic factors on tuberculosis transmission rate in European cities: meta-analysis of molecular epidemiological studies Source: Annual Congress 2009 - Socio-economic impact of tuberculosis Year: 2009 Prevalence of COPD in the general population according to cardiovascular risk factors Source: Eur Respir J 2007; 30: Suppl. 51, 778s Year: 2007 Is smoking a major risk factor for COVID-19 infection and severe disease? Source: Virtual Congress 2020 – Smoking, nicotine and COVID-19 myths and facts. What is the evidence? Year: 2020